Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Obesity, dyslipidemia, hypertension, insulin resistance, and hyperglycemia may all be successfully managed with dietary and physical activity changes
Exposure to heat, light, or air can compromise the liposomal structure and reduce bioavailability, making proper storage essential for maintaining product quality
Contains goat's milk, rich in vitamins, minerals, and essential fatty acids, protecting skin's natural acids and moisture
Retatrutide led to dose-dependent reductions in body weight of up to 24.2% at 48 weeks, with a safety profile comparable to other GLP-1-based therapies. Jastreboff et al., NEJM Secondary Benefits Improved HbA1c in both diabetic and pre-diabetic participants Significant reductions in liver fat (a marker for NAFLD/NASH reversal) Lowered triglycerides, LDL, and inflammatory markers Favorable impact on blood pressure and fasting insulin levels Tolerability and Safety Most side effects were GI-related and dose-dependent : Nausea Constipation Occasional vomiting All were similar in frequency and severity to those seen in Semaglutide trials No serious adverse events were reported Dropout rates were low across all dose groups These results suggest Retatrutide may offer not only more dramatic weight loss , but also better metabolic improvements and potential muscle-sparing advantages making it a standout candidate for both medical and performance-focused applications
USA 109 , 53285333 (2012)
The combination group had a significantly lower 10-year atherosclerosis and cardiovascular disease risk (a multicomponent measure of risk of a cardiac event within a 10-year window) at the end of the study compared with the statin-only group
